Impax Asset Management Group plc
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1749768
LONDON, X0
Position in LGND
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$41,091,700
+$10,656,256 QoQ
Shares Held
130,000
-14.7% QoQ
Ownership
0.652%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#39
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Impax Asset Management Group plc holds $114,915,981 across 7 Biotechnology names. LGND ranks #1 (35.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
130,000 | $41,091,700 | |
| 2 | TVTX |
Travere Therapeutics, Inc.
|
300,000 | $17,043,000 | |
| 3 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
435,000 | $16,277,700 | |
| 4 | CYTK |
Cytokinetics Inc
|
165,000 | $14,056,350 | |
| 5 | TECH |
BIO-TECHNE Corp
|
195,000 | $13,776,750 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
300,000 | $10,617,000 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,134 | $2,053,481 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,091,700 | 130,000 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $30,435,444 | 152,444 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $31,235,876 | 165,208 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $35,464,845 | 200,208 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $29,580,445 | 260,208 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $29,461,069 | 280,208 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $30,024,287 | 280,208 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $28,046,018 | 280,208 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $23,610,326 | 280,208 | Shares | Defined | 2024-11-08 | |
| 2024-03-31 | $18,655,704 | 255,208 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $14,655,955 | 205,208 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $11,044,454 | 184,320 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $11,486,972 | 159,320 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $14,294,179 | 194,320 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $15,652,576 | 234,320 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $20,177,284 | 234,320 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $16,445,018 | 184,320 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $18,484,364 | 164,320 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $20,824,290 | 134,820 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,837,256 | 99,320 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $10,405,990 | 79,320 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $12,868,452 | 84,411 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $12,487,633 | 125,567 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $11,969,045 | 125,567 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $13,067,319 | 116,829 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,495,797 | 116,829 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||